Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer

Urology

Volumn 63, Issue 2, 2004, Pages 268-272

  Kurokawa, Kohei ^a,b   Ito, Kazuto ^a   Yamamoto, Takumi ^a   Takechi, Hiroyuki ^a   Miyamoto, Shigeto ^a   Suzuki, Kazuhiro ^a   Yamanaka, Hidetoshi ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER SCREENING; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 1242319251     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2003.09.027     Document Type: Article

References (11)

1. Mahadevia P.S., Koss L.G., Tar I.J. Prostatic involvement in bladder cancer prostate mapping in 20 cystoprostatectomy specimens . Cancer. 58:1986;2096-2102.
2. Montie J.E., Wood D.P., Pontes J.E., et al. Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer. 63:1989;381-385.
3. Chun T.Y. Coincidence of bladder and prostate cancer. J Urol. 157:1997;65-67.
4. Kurokawa K., Suzuki K., Okazaki H., et al. Usefulness of PSA screening in outpatients with bladder cancer preliminary results . Int J Urol. 9:2002;237-240.
5. Pritchett T.R., Moreno J., Warner N.E., et al. Unsuspected prostatic adenocarcinoma in patients who have undergone radical cystoprostatectomy for transitional cell carcinoma of the bladder. J Urol. 139:1988;1214-1216.
6. Stamey T.A., Freiha F.S., McNeal J.E., et al. Localized prostate cancer relationship of tumor volume to clinical significance for treatment of prostate cancer . Cancer. 71:1993;933-938.
7. Cancer statistics in Japan: cancer incidence, crude rates and age-specific rates per 100,000 population in Japan according to sex and site (1996). Available at http://www.ncc.go.jp/en/statistics/2001/tables/t07.html . Accessed July 16, 2003.
8. Singh A., Jones R.F., Friedman H., et al. Expression of p53 and pRb in bladder and prostate cancer of patients having both cancers. Anticancer Res. 19:1999;5415-5417.
9. Amara N., Palapattu G.S., Schrage M., et al. Prostate stem cell antigen is overexpressed on human transitional cell carcinoma. Cancer Res. 61:2001;4660-4665.
10. Cheng L., Reiter R.E., Jin Y., et al. Immunocytochemical analysis of prostate stem cell antigen as an adjunct marker for the detection of urothelial transitional cell carcinoma in voided urine specimens. J Urol. 169:2003;2094-2100.
11. Wang C.Y., Jones R.F., Debiec-Rychter M., et al. Correlation of the genotypes for N-acetyltransferases 1 and 2 with double bladder and prostate cancers in a case-comparison study. Anticancer Res. 22:2002;3529-3535.